Delivery Order SPE2DR25D1109-SPE2DR26FFJ9B
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vitamin K-1 10 mg/ml ampules, valued at $3,568.08 under a firm fixed-price contract type. The award was made on June 25, 2025, with an ultimate completion date of June 26, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to compete...
- The Defense Logistics Agency awarded a $2,175.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vitamin K-1 10 mg/ml ampules, with performance in Conshohocken, Pennsylvania and an ultimate completion date of August 21, 2025. This non-set-aside competitive award represents a routine pharmaceutical supply transaction under the company's broader federal contract portfolio. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of the Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $3,732.25 firm-fixed-price delivery order is for the supply of 4,564,814,393 units of the blood-clotting medication KCENTRA 500 UNIT VIALS. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a $1,452.64 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Phytonadione 10 mg/ml ampules. This is a firm fixed price contract with no set-aside designation, classified as a child contract under a larger vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. Phytonadione, commonly known as Vitamin K1, is a critical...
- The Defense Logistics Agency awarded a $4,577.30 delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Phytonadione 10 mg/ml ampules, with completion targeted for December 31, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $38,816.78 to AmerisourceBergen Drug Corp for the supply of Kengreal 50 mg vials. This firm fixed-price delivery order, with an ultimate completion date of September 23, 2025, was awarded on a competitive basis without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract represents a child order under...
- The U.S. Department of Defense Medical Supply Chain awarded a $2,701.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Phytonadione 10 mg/ml ampules, with an ultimate completion date of August 4, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded...
- The Defense Logistics Agency (DLA) awarded a $7,595.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Kanjinti 420 mg vials, with an ultimate completion date of December 22, 2025. This non-set-aside contract represents a specific product delivery under the company's broader pharmaceutical supply relationship with DLA. The work will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL units, valued at $3,037.93. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 22, 2025. Phytonadione, commonly...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Phytonadione 10 mg/ml in ampule form, with a contract ceiling value of $2,026.26 and an ultimate completion date of September 4, 2025. This competitively awarded, non-set-aside delivery order carries firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFJ9BDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,808.45 to AmerisourceBergen Drug Corp for 500 unit vials of Kcentra, a vitamin K-dependent clotting factor concentrate used in emergency medical settings. This firm fixed price delivery order, issued on December 31, 2025, is expected to be completed by January 23, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order placed under AmerisourceBergen Drug Corp's existing contract vehicle with the Defense Logistics Agency. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp serves the Defense Health Agency and other government healthcare systems through this comprehensive contract vehicle. The pharmaceutical prime vendor arrangement allows the Defense Logistics Agency to efficiently procure essential medications and medical supplies across multiple therapeutic domains to support military medical readiness and operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 12/30/25 |